Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 19 results.
User Information
Export Records
  1. 1.   Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practices
  2. Chen, Tony; Pham, Giang; Fox, Louis; Adler, Nina; Wang,Kevin; Zhang, Jingning; Byun, Jinyoung; Han, Younghun; Saunders, Gretchen R B; Liu, Dajiang; Bray, Michael J; Ramsey, Alex T; McKay, James; Bierut, Laura J; Amos, Christopher I; Hung, Rayjean J; Lin, Xihong; Zhang, Haoyu; Chen, Li-Shiun
  3. EBioMedicine. 2024, Nov 08; 110: 105441.
  1. 2.   Moving towards an evidence-informed cancer control strategy: A scoping review of oncology research in Kenya
  2. Manduku, Veronica; Akhavan, Mina; Asiki, Gershim; Brand, Nathan R.; Cira,Mishka; Gura, Zeinab; Kadengye, Damazo T.; Karagu, Alfred; Livinski, Alicia A.; Meme, Helen; Kyobutungi, Catherine
  3. JOURNAL OF CANCER POLICY. 2020, JUN; 24: 100219.
  1. 3.   Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial
  2. Bobe, G.; Murphy, G.; Albert, P. S.; Sansbury, L. B.; Lanza, E.; Schatzkin, A.; Cross, A. J.
  3. International Journal of Cancer. 2012, Apr; 130(7): 1649-1659.
  1. 4.   Nothospondin, a new AP-1 inhibitory quassinoid from the Cameroonian plant Nothospondias staudtii
  2. Diyabalanage, T.; Ratnayake, R.; Wilson, J. A.; Henrich, C. J.; Beutler, J. A.; Colburn, N. H.; McMahon, J. B.; Gustafson, K. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, Aug; 21(15): 4397-4399.
  1. 5.   Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial
  2. Bobe, G.; Murphy, G.; Albert, P. S.; Sansbury, L. B.; Lanza, E.; Schatzkin, A.; Colburn, N. H.; Cross, A. J.
  3. British Journal of Cancer. 2010, Oct; 103(9): 1453-1461.
  1. 6.   C/EBP beta regulates body composition, energy balance-related hormones and tumor growth
  2. Staiger, J.; Lueben, M. J.; Berrigan, D.; Malik, R.; Perkins, S. N.; Hursting, S. D.; Johnson, P. F.
  3. Carcinogenesis. 2009 30(5): 832-840.
  1. 7.   Effects of selenium supplementation on expression of glutathione peroxidase isoforms in cultured human lung adenocarcinoma cell lines
  2. Romanowska, M.; Kikawa, K. D.; Fields, J. R.; Maciag, A.; North, S. L.; Shiao, Y. H.; Kasprzak, K. S.; Anderson, L. M.
  3. Lung Cancer. 2007, Jan; 55(1): 35-42.
  1. 8.   Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry
  2. Xu, X.; Veenstra, T. D.; Fox, S. D.; Roman, J. M.; Issaq, H. J.; Falk, R.; Saavedra, J. E.; Keefer, L. K.; Ziegler, R. G.
  3. Analytical Chemistry. 2005, OCT 15; 77(20): 6646-6654.
  1. 9.   Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappa B activation and transformation in resistant JB6 cells
  2. Hu, J.; Nakano, H.; Sakurai, H.; Colburn, N. H.
  3. Carcinogenesis. 2004, OCT; 25(10): 1991-2003.
  1. 10.   Measuring seven endogenous ketolic estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry
  2. Xu, X.; Keefer, L. K.; Waterhouse, D. J.; Saavedra, J. E.; Veenstra, T. D.; Ziegler, R. G.
  3. Analytical Chemistry. 2004, OCT 1; 76(19): 5829-5836.
  1. 11.   Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice
  2. Felix, K.; Gerstmeier, S.; Kyriakopoulos, A.; Howard, O. M. Z.; Dong, H. F.; Eckhaus, M.; Behne, D.; Bornkamm, G. W.; Janz, S.
  3. Cancer Research. 2004 64(8): 2910-2917.
  1. 12.   Serum proteomic profiles suggest celecoxib-modulated targets and response predictors
  2. Zhen, X. A.; Luke, B. T.; Izmirlian, G.; Umar, A.; Lynch, P. M.; Phillips, R. K. S.; Patterson, S.; Conrads, T. P.; Veenstra, T. D.; Greenwald, P.; Hawk, E. T.; Ali, L. U.
  3. Cancer Research. 2004 64(8): 2904-2909.
  1. 13.   Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation
  2. Dhar, A.; Hu, J.; Reeves, R.; Resar, L. M. S.; Colburn, N. H.
  3. Oncogene. 2004 23(25): 4466-4476.
  1. 14.   Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice
  2. Berrigan, D.; Perkins, S. N.; Haines, D. C.; Hursting, S. D.
  3. Carcinogenesis. 2002 23(5): 817-822.
  1. 15.   Protection against human papillomavirus type 16-E7 oncogene- induced tumorigenesis by in vivo expression of dominant- negative c-jun
  2. Young, M. R.; Farrell, L.; Lambert, P.; Awasthi, P.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2002 34(2): 72-77.
  1. 16.   The effects of resveratrol on CYP1A1 expression and aryl hydrocarbon receptor function in vitro
  2. Ciolino, H. P.; Yeh, G. C.
  3. Nutrition and Cancer Prevention. 2001; 492 : 183-193.
  1. 17.   Diosmin and Diosmetin Are Agonists of the Aryl Hydrocarbon Receptor That Differentially Affect Cytochrome P450 1a1 Activity
  2. Ciolino, H. P.; Wang, T. T. Y.; Yeh, G. C.
  3. Cancer Research. 1998 58(13): 2754-2760.
  1. 18.   P53-Independent Inhibition of Nitric Oxide Generation By Cancer Preventive Interventions in Ex Vivo Mouse Peritoneal Macrophages
  2. Mei, J. J. M.; Hursting, S. D.; Perkins, S. N.; Phang, J. M.
  3. Cancer Letters. 1998 129(2): 191-197.
  1. 19.   Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor
  2. Ciolino, H. P.; Daschner, P. J.; Yeh, G. C.
  3. Cancer Research. 1998 58(24): 5707-5712.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel